The U.S. Federal Trade Commission has asked Amazon.com to provide more details on its deal to hire top executives and researchers from artificial intelligence startup Adept, a person familiar with the matter told Reuters.
The Federal Trade Commission (FTC) has made a "second request" for additional information around IBM's (IBM) plan to acquire cloud software company HashiCorp (HCP) for $6.4 billion.
The agency plans to file lawsuits targeting the business practices related to rebates brokered with drug manufacturers, the Journal reported.
The Federal Trade Commission is planning to sue three large U.S. health companies over their practices as middlemen who negotiate prices for medications such as insulin, a source familiar with the matter told CNBC. The suits are set to target the three biggest so-called pharmacy benefit managers, UnitedHealth Group's Optum Rx, CVS Health's Caremark and Cigna's Express Scripts, which are all owned by or connected to health insurers.
The $4 billion takeover by bedding group Tempur Sealy International (NYSE:TPX) of Mattress Firm Group Inc is facing a legal challenge from the US antitrust agency. Overnight, the Federal Trade Commission took the deal to federal court to block the combination of the largest US mattress maker with the biggest bedding retailer.
NEW YORK — The Federal Trade Commission is taking action against a gig-work company, saying it misled people about the money they could make on its platform.
The commission said the acquisition could hike prices for consumers, take out competitors and cut jobs at rival mattress companies.
The Federal Trade Commission voted to file a lawsuit to block the proposed $4 billion merger between Tempur Sealy and Mattress Firm over concerns about its competitive impact.
Teva Pharmaceuticals Industries Ltd.'s stock fell 2% Monday after a report said the Federal Trade Commission has opened an investigation into the Israeli generics company, citing its refusal to take down roughly two dozen patents for its asthma and COPD inhalers.
The U.S. Federal Trade Commission has opened an investigation into Teva Pharmaceutical over the company's refusal to take down about two dozen patents for its asthma and COPD inhalers, the Washington Post reported on Monday, citing agency documents.
The news of the U.S. government's allegations has shaken the financial sector. Adobe is at the center of a criticism storm from the Federal Trade Commission (FTC), which claims that the company concealed the cost of canceling its subscription plan.
The Federal Trade Commission (FTC) is taking action against Adobe and two of its executives, alleging that they deceived consumers by hiding an early termination fee on a subscription plan and making it difficult for customers to cancel their subscriptions.